Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis
Yao Chen, Bingjun Bai, Shuchang Ye, Xing Gao, Xinnan Zheng, Kangkang Ying, Hongming Pan, Binbin Xie · 2023
Read Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis by Yao Chen, Bingjun Bai, Shuchang Ye, Xing Gao, Xinnan Zheng, Kangkang Ying, Hongming Pan, Binbin Xie (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10699048.txt.
Description
Chen and seven co-authors use genetics to test whether the diabetes drug metformin lowers cancer risk. Reports have hinted at protection, but ordinary studies cannot prove cause. Mendelian randomization uses inherited gene variants as a natural experiment to get closer to causal answers.
Across 26 cancers, only one link stood firm: metformin use tied to much lower odds of HER-positive breast cancer. Other cancers showed only modest hints. A two-step analysis suggested testosterone levels carried about a quarter of the protective effect. Repeated checks with other methods agreed. The authors present metformin as a candidate preventive for that breast cancer type.
Catalog record
| CREATOR | Yao Chen, Bingjun Bai, Shuchang Ye, Xing Gao, Xinnan Zheng, Kangkang Ying, Hongming Pan, Binbin Xie |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |